Odile Mercereau‐Puijalon

Author

Also Known As

Mercereau-Puijalon, O., Mercereau-Puijalon, Odile, O MERCEREAU-PUIJALON, O Mercereau-Puijalon, O. MERCEREAU-PUIJALON, O. MERCEREAU‐PUIJALON, O. Mercereau-Puijalon, O. Mercereaupuijalon, O. Mercereau‐Puijalon, ODILE MERCEREAU-PUIJALON

250

Publications

17.2K

Citations

H-Index

117

Concepts

All Affiliations

Institut Pasteur Centre National de la Recherche Scientifique Institut Pasteur de Dakar Inserm Institut Pasteur du Cambodge

About

Odile Mercereau‐Puijalon is an author at Institut Pasteur specializing in medicine, malaria, and pathogenesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	87	8.6K
2	Natural Sciences	24	32	2.2K
3	Public Health	6	6	459
4	Engineering	3	3	229
5	Health Sciences	3	3	155

Odile Mercereau‐Puijalon

175

Publications

15.7K

Citations

H-Index

Page 1

	Year	Citations
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria Frédéric Ariey, Benoît Witkowski, Chanaki Amaratunga, Nature Antiparasitic AgentMalariaMolecular BiologyParasite GenomicsMedicine	2013	2.1K
K13-propeller mutations confer artemisinin resistance in <i>Plasmodium falciparum</i> clinical isolates Judith Straimer, Nina F. Gnädig, Benoît Witkowski, Science GeneticsMalariaMolecular BiologyMolecular GeneticsGenomics	2014	709
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies Benoît Witkowski, Chanaki Amaratunga, Nimol Khim, The Lancet Infectious Diseases Ex-vivo Drug-response StudiesAntiparasitic AgentBioanalysisPharmacologyMalaria	2013	623
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms Didier Ménard, Nimol Khim, Johann Beghain, New England Journal of Medicine	2016	542
Resistance of Plasmodium falciparum Field Isolates to In-Vitro Artemether and Point Mutations of the SERCA-Type PfATPase6 Ronan Jambou, Eric Legrand, Makhtar Niang, Yearbook of Dermatology and Dermatologic Surgery Disease ResistanceDrug Resistance AnalysisPoint MutationsPathogenesisMalaria	2005	500
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study Benoît Witkowski, Valentine Duru, Nimol Khim, The Lancet Infectious Diseases	2016	390
<i>Plasmodium vivax</i> clinical malaria is commonly observed in Duffy-negative Malagasy people Didier Ménard, Céline Barnadas, Christiane Bouchier, Proceedings of the National Academy of Sciences	2010	379
Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study Jean‐François Trape, Adama Tall, Nafissatou Diagne, The Lancet Infectious Diseases Antiparasitic AgentPesticide ResistanceMalariaPharmacologyInsecticide-treated Bednets	2011	332
Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia Benoît Witkowski, Nimol Khim, Pheaktra Chim, Antimicrobial Agents and Chemotherapy Antiparasitic AgentMedicineMalariaBioanalysisParasite Control	2012	279
The Toxoplasma gondii rhoptry protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm. C J Beckers, J. F. Dubremetz, Odile Mercereau‐Puijalon, The Journal of Cell Biology Parasitic DiseaseIntracellular ParasiteParasitic ProtozoaPathogenesisImmunology	1994	219

Page 1